Local Delivery of the KCa3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-induced Coronary Smooth Muscle Phenotypic Modulation and Limits Stenosis

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2008 Mar 1

PMID 18309114

Citations 56

Authors

D L Tharp

B R Wamhoff

H Wulff

G Raman

A Cheong

D K Bowles

Affiliations

Soon will be listed here.

Abstract

Objective: We previously demonstrated that upregulation of intermediate-conductance Ca(2+)-activated K(+) channels (K(Ca)3.1) is necessary for mitogen-induced phenotypic modulation in isolated porcine coronary smooth muscle cells (SMCs). The objective of the present study was to determine the role of K(Ca)3.1 in the regulation of coronary SMC phenotypic modulation in vivo using a swine model of postangioplasty restenosis.

Methods And Results: Balloon angioplasty was performed on coronary arteries of swine using either noncoated or balloons coated with the specific K(Ca)3.1 blocker TRAM-34. Expression of K(Ca)3.1, c-jun, c-fos, repressor element-1 silencing transcription factor (REST), smooth muscle myosin heavy chain (SMMHC), and myocardin was measured using qRT-PCR in isolated medial cells 2 hours and 2 days postangioplasty. K(Ca)3.1, c-jun, and c-fos mRNA levels were increased 2 hours postangioplasty, whereas REST expression decreased. SMMHC expression was unchanged at 2 hours, but decreased 2 days postangioplasty. Use of TRAM-34 coated balloons prevented K(Ca)3.1 upregulation and REST downregulation at 2 hours, SMMHC and myocardin downregulation at 2 days, and attenuated subsequent restenosis 14 and 28 days postangioplasty. Immunohistochemical analysis demonstrated corresponding changes at the protein level.

Conclusions: Blockade of K(Ca)3.1 by delivery of TRAM-34 via balloon catheter prevented smooth muscle phenotypic modulation and limited subsequent restenosis.

Citing Articles

Increased KCNN4 Expression Is Correlated With Poor Survival in Lower Grade Glioma.

Lehrer S, Rheinstein P Cancer Diagn Progn. 2023; 3(4):428-432.

PMID: 37405224 PMC: 10316058. DOI: 10.21873/cdp.10235.

Ca-Activated K Channels and the Regulation of the Uteroplacental Circulation.

Hu X, Zhang L Int J Mol Sci. 2023; 24(2).

PMID: 36674858 PMC: 9867535. DOI: 10.3390/ijms24021349.

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K3.1) channels .

Brommel K, Paul Konken C, Borgel F, Obeng-Darko H, Schelhaas S, Bulk E RSC Adv. 2022; 11(48):30295-30304.

PMID: 35480282 PMC: 9041111. DOI: 10.1039/d1ra03850h.

Kv1.3 Channel Inhibition Limits Uremia-Induced Calcification in Mouse and Human Vascular Smooth Muscle.

Cazana-Perez V, Cidad P, Navarro-Gonzalez J, Rojo-Mencia J, Jaisser F, Lopez-Lopez J Function (Oxf). 2022; 2(1):zqaa036.

PMID: 35330975 PMC: 8788811. DOI: 10.1093/function/zqaa036.

K3.1 Inhibition Decreases Size and Alters Composition of Atherosclerotic Lesions Induced by Low, Oscillatory Flow.

Tharp D, Bowles D Artery Res. 2021; 27(2):93-100.

PMID: 34457083 PMC: 8388312. DOI: 10.2991/artres.k.210202.001.

References

Camenzind E . Treatment of in-stent restenosis--back to the future?. N Engl J Med. 2006; 355(20):2149-51. DOI: 10.1056/NEJMe068215. View

Carter A, Laird J, Farb A, Kufs W, Wortham D, Virmani R . Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994; 24(5):1398-405. DOI: 10.1016/0735-1097(94)90126-0. View

Hendrix J, Wamhoff B, McDonald O, Sinha S, Yoshida T, Owens G . 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest. 2005; 115(2):418-27. PMC: 546420. DOI: 10.1172/JCI22648. View

Doi H, Iso T, Yamazaki M, Akiyama H, Kanai H, Sato H . HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler Thromb Vasc Biol. 2005; 25(11):2328-34. DOI: 10.1161/01.ATV.0000185829.47163.32. View

Wamhoff B, Bowles D, McDonald O, Sinha S, Somlyo A, Somlyo A . L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res. 2004; 95(4):406-14. DOI: 10.1161/01.RES.0000138582.36921.9e. View

Chen J, Kitchen C, Streb J, Miano J . Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002; 34(10):1345-56. DOI: 10.1006/jmcc.2002.2086. View

Wang Z, Wang D, Teg Pipes G, Olson E . Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A. 2003; 100(12):7129-34. PMC: 165841. DOI: 10.1073/pnas.1232341100. View

Kantor B, Ashai K, Holmes Jr D, Schwartz R . The experimental animal models for assessing treatment of restenosis. Cardiovasc Radiat Med. 2001; 1(1):48-54. DOI: 10.1016/s1522-1865(98)00005-5. View

Bar H, Wende P, Watson L, Denger S, Van Eys G, Kreuzer J . Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res Cardiol. 2002; 97(1):9-16. DOI: 10.1007/s395-002-8382-z. View

10.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

11.

Neylon C, Lang R, Fu Y, Bobik A, Reinhart P . Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res. 1999; 85(9):e33-43. DOI: 10.1161/01.res.85.9.e33. View

12.

Li S, Wang D, Wang Z, Richardson J, Olson E . The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A. 2003; 100(16):9366-70. PMC: 170924. DOI: 10.1073/pnas.1233635100. View

13.

Schwartz R, Murphy J, Edwards W, Camrud A, Vliestra R, Holmes D . Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation. 1990; 82(6):2190-200. DOI: 10.1161/01.cir.82.6.2190. View

14.

Proweller A, Pear W, Parmacek M . Notch signaling represses myocardin-induced smooth muscle cell differentiation. J Biol Chem. 2005; 280(10):8994-9004. DOI: 10.1074/jbc.M413316200. View

15.

Owens G, Kumar M, Wamhoff B . Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84(3):767-801. DOI: 10.1152/physrev.00041.2003. View

16.

Bowles D, Maddali K, Ganjam V, Rubin L, Tharp D, Turk J . Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle. Am J Physiol Heart Circ Physiol. 2004; 287(5):H2091-8. DOI: 10.1152/ajpheart.00258.2004. View

17.

Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier J, Shakkottai V . Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem. 2007; 14(13):1437-57. DOI: 10.2174/092986707780831186. View

18.

Cheong A, Wood I, Beech D . Less REST, more vascular disease? Regulation of cell cycle and migration of vascular smooth muscle cells. Cell Cycle. 2005; 5(2):129-31. DOI: 10.4161/cc.5.2.2310. View

19.

Wulff H, Gutman G, Cahalan M, Chandy K . Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem. 2001; 276(34):32040-5. DOI: 10.1074/jbc.M105231200. View

20.

Schwartz R, Topol E, Serruys P, Sangiorgi G, Holmes Jr D . Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol. 1998; 32(7):2087-94. DOI: 10.1016/s0735-1097(98)00500-2. View